Loading
Latest filing published 30 Jun 2025 for Bliss GVS Pharma Limited, €4,204.
Gagan Harsh Sharma appears in our data through filings on Bliss GVS Pharma Limited shares, published by SEBI (PIT + SAST). In total, 3 filings cover trades dated from 25 June 2025 to 27 June 2025.
No open-market sale appears; the market trades are 3 purchases worth €52k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €11k. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 30 June 2025 with an open-market purchase (€4,204) in Bliss GVS Pharma Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations